139 related articles for article (PubMed ID: 7700292)
1. Survival of dopaminergic neurons in fetal-tissue grafts.
Hoffer BJ; van Horne C
N Engl J Med; 1995 Apr; 332(17):1163-4. PubMed ID: 7700292
[No Abstract] [Full Text] [Related]
2. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
Kirik D; Björklund A
Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
[No Abstract] [Full Text] [Related]
3. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
Kordower JH; Freeman TB; Olanow CW
Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
[No Abstract] [Full Text] [Related]
4. [Long-term survival of fetal substantia nigra grafts in striatum of PD rats: an observation of tyrosine hydroxylase immunohistochemistry and western blot].
Yang H; Cai W; Zhang K
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):13-5. PubMed ID: 10374499
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Snow BJ; Vingerhoets FJ; Mufson EJ; Sanberg PR; Hauser RA; Smith DA; Nauert GM; Perl DP
N Engl J Med; 1995 Apr; 332(17):1118-24. PubMed ID: 7700284
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.
Emgård M; Karlsson J; Hansson O; Brundin P
Exp Neurol; 1999 Nov; 160(1):279-88. PubMed ID: 10630212
[TBL] [Abstract][Full Text] [Related]
7. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
8. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
Mendez I; Elisevich K; Flumerfelt B
J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
[TBL] [Abstract][Full Text] [Related]
10. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
Yang H; Zhang K; Cai W
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations.
Mendez I; Dagher A; Hong M; Hebb A; Gaudet P; Law A; Weerasinghe S; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
J Neurosurg; 2000 May; 92(5):863-9. PubMed ID: 10794303
[TBL] [Abstract][Full Text] [Related]
12. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
Mendez I; Sanchez-Pernaute R; Cooper O; Viñuela A; Ferrari D; Björklund L; Dagher A; Isacson O
Brain; 2005 Jul; 128(Pt 7):1498-510. PubMed ID: 15872020
[TBL] [Abstract][Full Text] [Related]
13. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
14. Encapsulated cell implantation for Parkinson's disease.
Christenson L; Emerich DF; Sanberg PR
Mov Disord; 1992; 7(2):185-6. PubMed ID: 1584240
[No Abstract] [Full Text] [Related]
15. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
[TBL] [Abstract][Full Text] [Related]
16. [Transplantation of embryonal nerve tissues in the treatment of Parkinson disease].
Bekhtereva NP; Gilerovich EG; Gurchin FA; Lukin VA; Matveeva TS; Otellin VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(11):10-3. PubMed ID: 1963958
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic graft-induced long-term recovery of complex sensorimotor behaviors in a rat model of Parkinson's disease.
Nikkhah G; Rosenthal C; Falkenstein G; Samii M
Zentralbl Neurochir; 1998; 59(2):97-103. PubMed ID: 9674098
[TBL] [Abstract][Full Text] [Related]
18. [Neurotransplantation in Parkinson disease: experimental and clinical results of functional reconstruction of the dopaminergic system].
Nikkhah G; Brandis A
Zentralbl Neurochir; 1995; 56(4):153-60. PubMed ID: 8571693
[TBL] [Abstract][Full Text] [Related]
19. Positive potential of fetal nigral implants for Parkinson disease.
Rosenberg RN
Arch Neurol; 2004 Jun; 61(6):837-8. PubMed ID: 15210519
[No Abstract] [Full Text] [Related]
20. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
